Cargando…

Nucleolin-based targeting strategies in cancer treatment: Focus on cancer immunotherapy (Review)

The benefits of treating several types of cancers using immunotherapy have recently been established. The overexpression of nucleolin (NCL) in a number of types of cancer provides an attractive antigen target for the development of novel anticancer immunotherapeutic treatments. NCL is a multifunctio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thongchot, Suyanee, Aksonnam, Krittaya, Thuwajit, Peti, Yenchitsomanus, Pa-Thai, Thuwajit, Chanitra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555485/ https://www.ncbi.nlm.nih.gov/pubmed/37477132 http://dx.doi.org/10.3892/ijmm.2023.5284

Ejemplares similares

Cellular localization of nucleolin determines the prognosis in cancers: a meta-analysis
por: Yangngam, Supaporn, et al.
Publicado: (2022)

Adoptive Transfer of Anti-Nucleolin T Cells Combined with PD-L1 Inhibition against Triple-Negative Breast Cancer
por: Thongchot, Suyanee, et al.
Publicado: (2022)

Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3/AKT pathways
por: Chuangchot, Nisa, et al.
Publicado: (2023)

Mesothelin-specific T cell cytotoxicity against triple negative breast cancer is enhanced by 40s ribosomal protein subunit 3-treated self-differentiated dendritic cells
por: Jirapongwattana, Niphat, et al.
Publicado: (2022)

Breast cancer stem cell RNA-pulsed dendritic cells enhance tumor cell killing by effector T cells
por: Sumransub, Nuttavut, et al.
Publicado: (2020)

Establishment and characterization of novel highly aggressive HER2-positive and triple-negative breast cancer cell lines
por: Thongchot, Suyanee, et al.
Publicado: (2021)

Periostin regulates autophagy through integrin α5β1 or α6β4 and an AKT‐dependent pathway in colorectal cancer cell migration
por: Thongchot, Suyanee, et al.
Publicado: (2020)

Interleukin-8 released by cancer-associated fibroblasts attenuates the autophagy and promotes the migration of ovarian cancer cells
por: Thongchot, Suyanee, et al.
Publicado: (2021)

HMGB1 mediates invasion and PD-L1 expression through RAGE-PI3K/AKT signaling pathway in MDA-MB-231 breast cancer cells
por: Amornsupak, Kamolporn, et al.
Publicado: (2022)

Development of an engineered peptide antagonist against periostin to overcome doxorubicin resistance in breast cancer
por: Oo, Khine Kyaw, et al.
Publicado: (2021)

High level of interleukin-33 in cancer cells and cancer-associated fibroblasts correlates with good prognosis and suppressed migration in cholangiocarcinoma
por: Yangngam, Supaporn, et al.
Publicado: (2020)

Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8
por: Sootichote, Rochanawan, et al.
Publicado: (2018)

Periostin induces epithelial-to-mesenchymal transition via the integrin α5β1/TWIST-2 axis in cholangiocarcinoma
por: Sonongbua, Jumaporn, et al.
Publicado: (2020)

Novel CSF1R-positive tenosynovial giant cell tumor cell lines and their pexidartinib (PLX3397) and sotuletinib (BLZ945)-induced apoptosis
por: Thongchot, Suyanee, et al.
Publicado: (2022)

Activation of cytotoxic T lymphocytes by self-differentiated myeloid-derived dendritic cells for killing breast cancer cells expressing folate receptor alpha protein
por: Luangwattananun, Piriya, et al.
Publicado: (2022)

The metabolic cross‐talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: Autophagy plays a role
por: Thuwajit, Chanitra, et al.
Publicado: (2017)

Increased ETV4 expression correlates with estrogen-enhanced proliferation and invasiveness of cholangiocarcinoma cells
por: Singsuksawat, Ekapot, et al.
Publicado: (2018)

Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells
por: Amornsupak, Kamolporn, et al.
Publicado: (2014)

Doxorubicin sensitizes breast cancer cells to natural killer cells in connection with increased Fas receptors
por: Sawasdee, Nunghathai, et al.
Publicado: (2022)

Chronic Inflammation and Cytokines in the Tumor Microenvironment
por: Landskron, Glauben, et al.
Publicado: (2014)

Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker
por: Utispan, Kusumawadee, et al.
Publicado: (2010)

DNA Methylation Markers Improve the Sensitivity of Endoscopic Retrograde Cholangiopancreatography-Based Brushing Cytology in Extrahepatic Cholangiocarcinoma
por: Prachayakul, Varayu, et al.
Publicado: (2017)

Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer
por: Soongsathitanon, Jarupa, et al.
Publicado: (2021)

Clustering of patients with intrahepatic cholangiocarcinoma based on serum periostin may be predictive of prognosis
por: Thuwajit, Chanitra, et al.
Publicado: (2017)

The microRNA-15a-PAI-2 axis in cholangiocarcinoma-associated fibroblasts promotes migration of cancer cells
por: Utaijaratrasmi, Penkhae, et al.
Publicado: (2018)

Carbonic anhydrase IX-related tumoral hypoxia predicts worse prognosis in breast cancer: A systematic review and meta-analysis
por: Numprasit, Warapan, et al.
Publicado: (2023)

Pyruvate Carboxylase Is Up-Regulated in Breast Cancer and Essential to Support Growth and Invasion of MDA-MB-231 Cells
por: Phannasil, Phatchariya, et al.
Publicado: (2015)

Roles of nucleolin: Focus on cancer and anti-cancer therapy
por: Chen, Zhuo, et al.
Publicado: (2016)

Nucleolin Therapeutic Targeting Decreases Pancreatic Cancer Immunosuppression
por: Ponzo, Matteo, et al.
Publicado: (2022)

Cancer Stem Cells and Nucleolin as Drivers of Carcinogenesis
por: Carvalho, Laura Sofia, et al.
Publicado: (2021)

Overexpression of Nucleolin and Associated Genes in Prostate Cancer
por: Firlej, Virginie, et al.
Publicado: (2022)

A novel nucleolin-binding peptide for Cancer Theranostics
por: Kim, Jae-Hyun, et al.
Publicado: (2020)

Nucleolin-targeted Extracellular Vesicles as a Versatile Platform for Biologics Delivery to Breast Cancer
por: Wang, Yayu, et al.
Publicado: (2017)

Evaluation of somatostatin and nucleolin receptors for therapeutic delivery in non-small cell lung cancer stem cells applying the somatostatin-analog DOTATATE and the nucleolin-targeting aptamer AS1411
por: Holmboe, Sif, et al.
Publicado: (2017)

Cancer-Associated Fibroblast-Derived IL-6 Determines Unfavorable Prognosis in Cholangiocarcinoma by Affecting Autophagy-Associated Chemoresponse
por: Thongchot, Suyanee, et al.
Publicado: (2021)

A water-soluble nucleolin aptamer-paclitaxel conjugate for tumor-specific targeting in ovarian cancer
por: Li, Fangfei, et al.
Publicado: (2017)

AS1411 Nucleolin-Specific Binding Aptamers Reduce Pathological Angiogenesis through Inhibition of Nucleolin Phosphorylation
por: Iturriaga-Goyon, Emilio, et al.
Publicado: (2021)

Targeting nucleolin to obstruct vasculature feeding with an intelligent DNA nanorobot
por: Li, Hua, et al.
Publicado: (2018)

Cancer Immunology with a Focus on Understudied Cancers as Targets for Immunotherapy
por: Young, M. Rita I.
Publicado: (2017)

Nanoengineered targeting strategy for cancer immunotherapy
por: Yin, Wei-min, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_t7vmamb9l1si2nt517pjapd0ki